# Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)

Source: https://welltoldgrants.com/grants/rfa-da-23-018-enabling-sud-digital-therapeutics-research-to-improve-payor/  
Official notice: https://www.grants.gov/search-results-detail/341593

> National Institutes of Health offered grants of up to $2.5 million to small businesses. Applications closed on November 15, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-DA-23-018 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | November 15, 2022 |
| Award ceiling | $2.5 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.279 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

To ensure that digital therapeutics that have been or are in the development for SUD are adopted, this funding opportunity concept aims to fund clinical trials that will generate convincing data to improve adoption by the payors.

## Questions people ask

### Is RFA-DA-23-018 still open?

No. It closed on November 15, 2022.

### Who can apply for Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)?

Closed November 15, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $2.5 million each.

### Who has been funded under RFA-DA-23-018?

NIH RePORTER lists 2 projects funded under RFA-DA-23-018 in fiscal 2023 to 2026, at 2 institutions. The most were at Biomedical Development Corporation, Charles River Analytics, Inc.

### Who has won Drug Use and Addiction Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.